PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-05-10

Date Title Company
10-May-2022 MODERNA TO HOST ANNUAL SCIENCE AND TECHNOLOGY DAY ON MAY 17, 2022 MODERNA
10-May-2022 Jazz Pharmaceuticals Completes U.S. Divestiture of Sunosi® (solriamfetol) to Axsome Therapeutics Jazz Pharmaceuticals
10-May-2022 UCB presents efficacy and safety results for zilucoplan and rozanolixizumab in generalized myasthenia gravis UCB
10-May-2022 Kaiku Health enters a strategic partnership to further improve patient outcomes through digital patient monitoring Kaiku Health
10-May-2022 AlzeCure presents the science behind NeuroRestore and TrkA-NAM at drug development conference AlzeCure
10-May-2022 Publication of Annual Financial Report Spectral MD Holdings, Ltd
10-May-2022 Moberg Pharma´s Interim report January - March 2022 Moberg Pharma
10-May-2022 Moberg Pharma begins patient enrollment in North American phase 3 study Moberg Pharma
10-May-2022 Three Rising Trends In Dental Chair Market Over 2022-2028 Global Market Insights
10-May-2022 FORXIGA (DAPAGLIFLOZIN) ACCEPTED FOR USE IN SCOTLAND FOR THE TREATMENT OF ADULT PATIENTS WITH CHRONIC KIDNEY DISEASE AstraZeneca
10-May-2022 NHS Scotland first in the UK to approve JYSELECA®▼ (filgotinib) for a form of Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC) Galapagos UK
10-May-2022 BioXcel Therapeutics Reports First Quarter 2022 Financial Results and Recent Operational Highlights BioXcel Therapeutics
10-May-2022 Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 31, 2022 Businesswire
10-May-2022 TheraVet Signs an Important Distribution Agreement With the Orthopaedics & Surgical Instrumentation Distributor, Veterinary Instrumentation Businesswire
10-May-2022 ABB publishes ABB Review, focused on digital solutions ABB
10-May-2022 International Society for Cell & Gene Therapy Presentations Illustrate Evox Therapeutics’ Proprietary Exosome Engineering Platform with New Data on Exosome Targeting and In Vivo Distribution Evox Therapeutics
10-May-2022 Achilles Therapeutics Doses First Patient with Higher-dose cNeT in Phase I/IIa CHIRON Trial in Advanced NSCLC and Initiates Enrollment in Cohort B of the THETIS Trial (cNeT + PD-1 checkpoint inhibitor) in Metastatic Malignant Melanoma Achilles Therapeutics
10-May-2022 Cegedim Healthcare Solutions leads discussion on pragmatic approaches to Population Health Management at this year’s Digital Healthcare Show Cegedim Healthcare Solutions
10-May-2022 Enara Bio and Collaborators Present Progress Towards Developing MR1-targeted T-Cell Therapies at 12th International CD1-MR1 EMBO Meeting Enara Bio
10-May-2022 Aqilion strengthens its pipeline with a drug candidate in chronic inflammatory bowel diseases, IBD Aqilion